MADERER, Annett et al. CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset. Acta Oncologica, [S. l.], v. 60, n. 11, p. 1543–1547, 2021. DOI: 10.1080/0284186X.2021.1959057. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/24028. Acesso em: 20 feb. 2025.